Is the liver function panel (five tests) performed via blood draw?
Abnormal liver function refers to a pathological state in which the liver is damaged due to external factors—i.e., harmful agents impair the liver, causing structural and morphological damage that subsequently leads to impaired hepatic function. So, does the “five-item liver function test” require blood drawing? Let’s explore this further below.
Does the Five-Item Liver Function Test Require Blood Drawing?
Yes, the five-item liver function test requires venipuncture. Blood must be drawn after an overnight fast for laboratory analysis. This test primarily evaluates key biochemical markers reflecting hepatic metabolic activity and includes albumin, transaminases, bilirubin, phosphatases, and collagen-related parameters. Abnormalities in these specific markers reflect distinct patterns and severities of hepatic tissue injury.

Albumin-related markers include prealbumin, albumin, cholinesterase, and total protein. Since the liver synthesizes these proteins essential for human physiology, abnormalities in these indicators reflect impaired hepatic synthetic function at the hepatocyte level.
Transaminases include alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), and adenosine deaminase (ADA). As transaminases act as critical “catalysts” in cellular metabolism—and are predominantly localized within hepatocytes—their serum levels serve as sensitive indicators of hepatocellular injury and its severity.
Bilirubin-related parameters include direct (conjugated) bilirubin, indirect (unconjugated) bilirubin, blood ammonia, and total bilirubin. Abnormalities in these markers typically arise when hepatic excretory, secretory, or detoxification functions are compromised.
Phosphatases—including alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), and nucleotidase—are predominantly expressed in the epithelial cells lining intrahepatic bile ducts. Elevations in these enzymes therefore indicate impaired biliary secretion or cholestasis.
Collagen-related markers include procollagen type III, collagen type IV, procollagen peptides, and hyaluronic acid. These substances are integral to the pathogenesis of hepatic fibrosis and cirrhosis; thus, their serum concentrations serve as valuable biomarkers for detecting early fibrotic changes and monitoring progression toward cirrhosis.